Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study-Reference-Cited by-同舟云学术

Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study

Published:2011-01-13 Issue:3 Volume:31 Page:412-416
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Wagenknecht Lynne E.,Palmer Nicholette D.,Bowden Donald W.,Rotter Jerome I.,Norris Jill M.,Ziegler Julie,Chen Yii-Der I.,Haffner Steven,Scherzinger Ann,Langefeld Carl D.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2010.02444.x/fullpdf

Reference19 articles.

1. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort;Wagenknecht;Obesity,2009

2. Prevelance of hepatic steatosis in an urban population in the United States;Browning;impact of ethnicity,2004

3. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease;Romeo;Nat Genet,2008

4. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans;Kotronen;Diabetologia,2009

5. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity;Sookoian;J Lipid Res,2009

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease;Hepatoma Research;2024

2. Global epidemiology of NAFLD;Metabolic Steatotic Liver Disease;2024

3. Gene Variants Implicated in Steatotic Liver Disease: Opportunities for Diagnostics and Therapeutics;Biomedicines;2023-10-17

4. Global incidence and prevalence of nonalcoholic fatty liver disease;Clinical and Molecular Hepatology;2023-02-28

5. Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies;Cancers;2022-12-20